Proof-of-Concept Study of Biomarker Development in Mice Provides a Roadmap for a Similar Approach in Humans

Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans. The findings, by principal investigator Amanda Paulovich, M.D., Ph.D., an associate member of the Hutchinson Center's Clinical Research Division, are published in Nature Biotechnology.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews